Out-licensing

This cell line may be used for elucidation of the mechanisms of CF, testing candidate complementary genes for correction of the observed CF abnormalities, and for developing and testing therapeutic CF drugs. More

Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms More

A new homogeneous technique which utilizes fluorescence resonance energy transfer (FRET) to directly detect and distinguish specific DNA sequences without requiring either an amplification step or a separation step has been developed. The detection... More

Mismatch-targeted transposition of Mu: a new strategy to map genetic polymorphism. More

Enhancing the dissolution performance of small and large molecules in a range of dosage forms More

Increasing the stability and improving the reconstitution of biomolecules using supercritical fluid (SCF) processing More

Crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More